NUCLEOLARON
Live / Registered — Registered (as of 23 May 2023)
What this means for you
Registered since 23 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97482649
- Registration number
- 7061973
- Mark type
- Stylized text
- Filed
- 30 Jun 2022
- Published for opposition
- 07 Mar 2023
- Registered
- 23 May 2023
- Attorney of record
- Boris Umansky
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use; Chemical reagents, other than for medical or veterinary purpose; Biochemical reagents used for non-medical purposes; Biochemical preparations for scientific purposes; Chemical preparations for transferring molecules, such as peptides, siRNA or DNA, into cells, for use in industry and scientific purposes; Chemicals used in industry and science
- Class 005 — Pharmaceuticals: Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Medicinal preparations for the treatment of muscular dystrophy, muscle diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, cancer, heart diseases and disorders, and brain diseases and disorders; Pharmaceutical preparations for the treatment of muscular dystrophy, muscle diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, cancer, heart diseases and disorders, and brain diseases and disorders; Pharmaceuticals for the treatment of muscular dystrophy, muscle diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, cancer, heart diseases and disorders, and brain diseases and disorders; Medicines for the treatment of muscular dystrophy, muscle diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, cancer, heart diseases and disorders, and brain diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Medicinal preparations for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Owner
- TOAGOSEI CO., LTD., MINATO-KU, TOKYO, JP
- TOAGOSEI CO., LTD., MINATO-KU, TOKYO, JP
- TOAGOSEI CO., LTD., MINATO-KU, TOKYO, JP
Prosecution history
- 23 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 07 Mar 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Mar 2023 — PUBLISHED FOR OPPOSITION
- 15 Feb 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Feb 2023 — ELECTRONIC RECORD REVIEW COMPLETE
- 27 Jan 2023 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 25 Jan 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Dec 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Dec 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Dec 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Oct 2022 — NON-FINAL ACTION E-MAILED
- 22 Oct 2022 — NON-FINAL ACTION WRITTEN
- 22 Oct 2022 — ASSIGNED TO EXAMINER